Gaëlle Munsch was awarded the Guy Meyer 2025 Thrombosis and Cancer Prize for her project to study the molecular determinants and mechanisms of recurrence in patients with cancer and thrombosis

After obtaining a Master’s degree in Public Health specialising in Biostatistics at ISPED, Gaëlle went on to do a thesis entitled ‘Statistical methodologies for the analysis of genetic determinants of venous thromboembolic disease and its recurrence’ under the supervision of David-Alexandre Trégouët of the BPH-ELEANOR team and Hélène Jacqmin-Gadda of the BIOSTAT-BPH team.

Her research aims to develop statistical models to identify :

• • • • genetic and molecular factors involved in venous thromboembolic disease, also known as thrombosis

• • • • biomarkers specific to this disease, as well as the mechanisms leading to its recurrence

Gaëlle was recently awarded the Guy Meyer 2025 Thrombosis and Cancer Prize for a project studying molecular determinants in patients with cancer and thrombosis.

This prize, attributed by Leo Pharma, is awarded to doctors, pharmacists, biologists or researchers under the age of 40, proposing an original, multi-disciplinary project which contributes to the advancement of research into thrombosis in oncology.
The €10,000 in funding obtained will be used to generate genetic data from a sub-sample of the EDITH-BREIZH cohort, which constitute important and unique databases for the study of the determinants of thrombosis coordinated at Brest University Hospital.
The aim of this project is to produce preliminary results with a view to resubmission to the ANR’s ‘Programme Jeunes Chercheuses Jeunes Chercheurs (JCJC)’ call for projects.

For the rest of her career, Gaëlle would like to continue in this field, studying in particular the determinants of cancer-associated thrombosis (CAT) and its complications.
In September 2025, she will join the  Inserm U1304-GETBO centre (Groupe d’étude de la Thrombose de Bretagne Occidentale) to continue her work and exploit the data from two large cohorts of patients with thrombosis: EDITH and EDITH-BREIZH, both coordinated by Prof. Francis Couturaud in Brest.